Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shimoni

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Leukemia|July 30, 2002
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysisA Shimoni, A Nagler, C Kaplinsky, et al.
Bone Marrow Transplantation|May 17, 2016
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantationP Tsirigotis, I Danylesko, K Gkirkas, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2012
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceS Le Gouill, N Kröger, N Dhedin, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
Leukemia|April 18, 2008
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myelomaG Schilling, T Hansen, A Shimoni, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Leukemia|July 30, 2002
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysisA Shimoni, A Nagler, C Kaplinsky, et al.
Bone Marrow Transplantation|May 17, 2016
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantationP Tsirigotis, I Danylesko, K Gkirkas, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2012
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceS Le Gouill, N Kröger, N Dhedin, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
Leukemia|April 18, 2008
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myelomaG Schilling, T Hansen, A Shimoni, et al.
Pageof 4